Plasmid DNA phosphate backbone (pDNA backbone)

The plasmid DNA phosphate backbone is the structural framework of circular, extrachromosomal DNA molecules used extensively in biotechnology and gene therapy (National Human Genome Research Institute, 2023). It consists of alternating deoxyribose sugar units and negatively charged phosphate groups linked by phosphodiester bonds, giving the molecule a high negative charge density (Alberts et al., 2002). This polyanionic nature is critical for its biological function, providing structural stability and serving as a site for interaction with various proteins and synthetic delivery vehicles (PubMed, PMC2737209). In a therapeutic context, the phosphate backbone is the primary target for cationic lipids and polymers, which condense the DNA into nanoparticles to facilitate cellular entry (Journal of Controlled Release, 2014). These interactions protect the genetic material from enzymatic degradation by nucleases during transport to the nucleus (Nature Reviews Drug Discovery, 2019). While not a traditional disease-causing target like a protein receptor, its chemical properties are exploited to deliver therapeutic genes for treating genetic disorders, cancer, and infectious diseases. The backbone's integrity is essential for the expression of the encoded transgene, making it a focal point for formulation science in non-viral gene delivery.

Other names

Phosphodiester backboneDeoxyribose-phosphate backboneDNA sugar-phosphate backbonePolyanionic DNA framework

Electrostatic condensation and neutralization of negative charges to facilitate membrane translocation and protection from nucleases (Journal of Controlled Release, 2014).